SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Carbogen Amc - Quaterly Results

09 Aug 2023 Evaluate
The sales is pegged at Rs. 695.50 millions for the June 2023 quarter. The mentioned figure indicates a decline of about -33.43% as against Rs. 1044.80 millions during the year-ago period.The Net Loss for the quarter ended June 2023 is Rs. -213.30 millions as compared to Net Loss of Rs. -248.30 millions of corresponding quarter ended June 2022Operating profit surged to 94.20 millions from the corresponding previous quarter of 75.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 695.50 1044.80 -33.43 695.50 1044.80 -33.43 4025.50 3066.10 31.29
Other Income 144.40 41.30 249.64 144.40 41.30 249.64 521.60 603.90 -13.63
PBIDT 94.20 75.60 24.60 94.20 75.60 24.60 599.20 999.00 -40.02
Interest 177.60 126.00 40.95 177.60 126.00 40.95 579.20 372.30 55.57
PBDT -83.40 -50.40 65.48 -83.40 -50.40 65.48 0.00 567.60 -100.00
Depreciation 246.90 346.50 -28.74 246.90 346.50 -28.74 962.00 1400.70 -31.32
PBT -330.30 -396.90 -16.78 -330.30 -396.90 -16.78 -962.00 -833.10 15.47
TAX -117.00 -148.60 -21.27 -117.00 -148.60 -21.27 -373.30 -528.40 -29.35
Deferred Tax -117.00 -148.60 -21.27 -117.00 -148.60 -21.27 -373.30 -221.60 68.46
PAT -213.30 -248.30 -14.10 -213.30 -248.30 -14.10 -588.70 -304.70 93.21
Equity 313.60 313.60 0.00 313.60 313.60 0.00 313.60 313.60 0.00
PBIDTM(%) 13.54 7.24 87.18 13.54 7.24 87.18 14.89 32.58 -54.32

Dishman Carbogen Amc Share Price

167.55 -1.05 (-0.62%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×